Molina Healthcare Reports Second Quarter 2023 Financial Results

Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today reported second quarter 2023 GAAP earnings per diluted share of $5.35 and adjusted earnings per diluted share of $5.65. Financial results are summarized below:

Three months ended

 

Six months ended

 

June 30,

 

June 30,

 

2023

 

2022

 

2023

 

2022

 

 

 

 

 

 

 

 

(In millions, except per-share results)

Premium Revenue

$8,042

 

$7,799

 

$15,927

 

$15,330

Total Revenue

$8,327

 

$8,054

 

$16,476

 

$15,824

 

 

 

 

 

 

 

 

GAAP:

 

 

 

 

 

 

 

Net Income

$309

 

$248

 

$630

 

$506

EPS – Diluted

$5.35

 

$4.25

 

$10.87

 

$8.63

Medical Care Ratio (MCR)

87.5%

 

88.1%

 

87.3%

 

87.6%

G&A Ratio

7.4%

 

6.8%

 

7.3%

 

7.1%

After-tax Margin

3.7%

 

3.1%

 

3.8%

 

3.2%

 

 

 

 

 

 

 

 

Adjusted:

 

 

 

 

 

 

 

Net Income

$327

 

$266

 

$664

 

$554

EPS – Diluted

$5.65

 

$4.55

 

$11.45

 

$9.45

G&A Ratio

7.4%

 

6.8%

 

7.3%

 

6.9%

After-tax Margin

3.9%

 

3.3%

 

4.0%

 

3.5%

 

 

 

 

 

 

 

 

See the Reconciliation of Unaudited Non-GAAP Financial Measures at the end of this release.

Quarter Highlights

• As of June 30, 2023, and including the early impact of Medicaid redeterminations, the Company served approximately 5.2 million members, an increase of 1% compared to June 30, 2022.
• Premium revenue was approximately $8.0 billion for the second quarter of 2023, an increase of 3% compared to the second quarter of 2022.
• GAAP net income was $5.35 per diluted share for the second quarter of 2023, an increase of 26% compared to the second quarter of 2022.
• Adjusted net income was $5.65 per diluted share for the second quarter of 2023, an increase of 24% compared to the second quarter of 2022.
• The Company increased its full year 2023 adjusted earnings guidance by $0.50 to at least $20.75 per diluted share, a 16% increase compared to 2022.

“Our performance this quarter supports our long-term outlook for revenue and earnings growth,” said Joseph Zubretsky, President and Chief Executive Officer. “We continue to build the revenue base and new store earnings profile, our operating results provide a very solid earnings base, and we have seen nothing in the early stages of the Medicaid redetermination process that changes our view of the earnings trajectory of the business.”

Premium Revenue

Premium revenue was $8.0 billion for the second quarter of 2023, an increase of 3% compared to the second quarter of 2022. The higher premium revenue reflects increased Medicaid and Medicare membership.

Net Income

GAAP net income for the second quarter of 2023 was $5.35 per diluted share, an increase of 26% compared to the second quarter of 2022. Adjusted net income for the second quarter of 2023 was $5.65 per diluted share, an increase of 24% compared to the second quarter of 2022.

Medical Care Ratio

• The consolidated MCR for the second quarter of 2023 was 87.5%, reflecting continued strong operating performance and medical cost management.
• The Medicaid MCR for the second quarter of 2023 was 88.3%, in line with the Company’s expectation and long-term target range.
• The Medicare MCR for the second quarter of 2023 was 89.2%, above the Company’s long‑term target range, reflecting higher utilization of outpatient and professional services and higher MCRs associated with membership growth.
• The Marketplace MCR for the second quarter of 2023 was 73.7%, reflecting the Company’s pricing strategy and seasonality.

General and Administrative Expense Ratio

The G&A ratio and the adjusted G&A ratio for the second quarter of 2023 were both 7.4%, reflecting new business implementation spending ahead of new contract wins commencing in July 2023 and next year.

Balance Sheet

Cash and investments at the parent company were $482 million as of June 30, 2023, compared to $375 million as of December 31, 2022.

Days in claims payable at June 30, 2023, was 47.

Cash Flow

Operating cash flow for the six months ended June 30, 2023, was $1,403 million, compared to $731 million for the six months ended June 30, 2022. The increase compared to the prior year was primarily due to the net impact of timing differences in government receivables and payables, and the growth in operations.

2023 Guidance

The Company increased its full year 2023 adjusted earnings per share guidance to at least $20.75, compared to the previous guidance of at least $20.25 per diluted share. The increase to earnings guidance reflects second quarter operating and investment income performance above the Company’s expectations and higher expected investment income in the second half of the year, partially offset by some continued conservatism.

See the Reconciliation of Unaudited Non-GAAP Financial Measures at the end of this release.

Conference Call

Management will host a conference call and webcast to discuss Molina Healthcare’s second quarter 2023 results at 8:00 a.m. Eastern Time on Thursday, July 27, 2023. The number to call for the interactive teleconference is [phone] and the confirmation number is 0165438. A telephonic replay of the conference call will be available through Thursday, August 3, 2023, by dialing [phone] and entering confirmation number 6917541. A live audio broadcast of this conference call will be available on Molina Healthcare’s website, molinahealthcare.com. A 30-day online replay will be available approximately an hour following the conclusion of the live broadcast.

About Molina Healthcare

Molina Healthcare, Inc., a FORTUNE 500 company (currently ranked 126), provides managed healthcare services under the Medicaid and Medicare programs and through the state insurance marketplaces. Molina Healthcare served approximately 5.2 million members as of June 30, 2023, located across 19 states. For more information about Molina Healthcare, please visit molinahealthcare.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

This earnings release and the Company’s accompanying oral remarks contain forward-looking statements regarding its 2023 guidance, Medicaid redeterminations, and future revenue growth. Actual results could differ materially due to numerous known and unknown risks and uncertainties. These risks and uncertainties are discussed under the headings “Forward-Looking Statements,” and “Risk Factors,” in the Company’s Annual Report on Form 10‑K for the year ended December 31, 2022, which is on file with the U.S. Securities and Exchange Commission (the “SEC”), and also in its Quarterly Report on Form 10-Q for the period ended June 30, 2023, which the Company expects to file on or about July 27, 2023.

These reports can be accessed under the investor relations tab of the Company’s website or on the SEC’s website at sec.gov. Given these risks and uncertainties, the Company can give no assurances that its forward-looking statements will prove to be accurate, or that any other results or developments projected or contemplated by its forward-looking statements will in fact occur, and the Company cautions investors not to place undue reliance on these statements. All forward-looking statements in this release represent the Company’s judgment as of July 26, 2023, and, except as otherwise required by law, the Company disclaims any obligation to update any forward-looking statement to conform the statement to actual results or changes in its expectations.

MOLINA HEALTHCARE, INC.
UNAUDITED CONSOLIDATED STATEMENTS OF INCOME
	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2023			2022			2023			2022
	(In millions, except per-share amounts)
Revenue:
Premium revenue	$	8,042		$	7,799		$	15,927		$	15,330
Premium tax revenue		169			215			341			423
Investment income		97			22			168			33
Other revenue		19			18			40			38
Total revenue		8,327			8,054			16,476			15,824
Operating expenses:
Medical care costs		7,038			6,872			13,909			13,435
General and administrative expenses		618			551			1,209			1,122
Premium tax expenses		169			215			341			423
Depreciation and amortization		42			44			86			84
Other		17			11			33			27
Total operating expenses		7,884			7,693			15,578			15,091
Operating income		443			361			898			733
Other expenses, net:
Interest expense		27			27			55			55
Total other expenses, net		27			27			55			55
Income before income tax expense		416			334			843			678
Income tax expense		107			86			213			172
Net income	$	309		$	248		$	630		$	506
Net income per share – Diluted	$	5.35		$	4.25		$	10.87		$	8.63
Diluted weighted average shares outstanding		57.9			58.4			58.0			58.6

MOLINA HEALTHCARE, INC.
CONSOLIDATED BALANCE SHEETS
	June 30,				December 31,
		2023				2022
	Unaudited
	(Dollars in millions, except per-share amounts)
ASSETS
Current assets:
Cash and cash equivalents	$	4,910			$	4,006
Investments		3,886				3,499
Receivables		2,385				2,302
Prepaid expenses and other current assets		260				277
Total current assets		11,441				10,084
Property, equipment, and capitalized software, net		285				259
Goodwill and intangible assets, net		1,348				1,390
Restricted investments		249				238
Deferred income taxes		220				220
Other assets		118				123
Total assets	$	13,661			$	12,314
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Medical claims and benefits payable	$	3,677			$	3,528
Amounts due government agencies		2,589				2,079
Accounts payable, accrued liabilities and other		857				889
Deferred revenue		414				359
Total current liabilities		7,537				6,855
Long-term debt		2,178				2,176
Finance lease liabilities		203				215
Other long-term liabilities		122				104
Total liabilities		10,040				9,350
Stockholders’ equity:
Common stock, $0.001 par value, 150 million shares authorized; outstanding: 58 million shares at each of June 30, 2023 and December 31, 2022		—				—
Preferred stock, $0.001 par value; 20 million shares authorized, no shares issued and outstanding		—				—
Additional paid-in capital		341				328
Accumulated other comprehensive loss		(146	)			(160	)
Retained earnings		3,426				2,796
Total stockholders’ equity		3,621				2,964
Total liabilities and stockholders’ equity	$	13,661			$	12,314

MOLINA HEALTHCARE, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
	Six Months Ended
	June 30,
		2023				2022
	(In millions)
Operating activities:
Net income	$	630			$	506
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		86				84
Deferred income taxes		(4	)			3
Share-based compensation		55				57
Other, net		5				(6	)
Changes in operating assets and liabilities:
Receivables		(83	)			(43	)
Prepaid expenses and other current assets		6				(64	)
Medical claims and benefits payable		149				405
Amounts due government agencies		510				247
Accounts payable, accrued liabilities and other		(208	)			(147	)
Deferred revenue		55				(357	)
Income taxes		202				46
Net cash provided by operating activities		1,403				731
Investing activities:
Purchases of investments		(924	)			(1,413	)
Proceeds from sales and maturities of investments		546				879
Purchases of property, equipment, and capitalized software		(63	)			(50	)
Other, net		2				(7	)
Net cash used in investing activities		(439	)			(591	)
Financing activities:
Common stock withheld to settle employee tax obligations		(59	)			(53	)
Common stock purchases		—				(200	)
Contingent consideration liabilities settled		—				(20	)
Other, net		4				5
Net cash used in financing activities		(55	)			(268	)
Net increase (decrease) in cash, cash equivalents, and restricted cash and cash equivalents		909				(128	)
Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period		4,048				4,506
Cash, cash equivalents, and restricted cash and cash equivalents at end of period	$	4,957			$	4,378

MOLINA HEALTHCARE, INC.
UNAUDITED SEGMENT DATA
(Dollars in millions)
		June 30,		December 31,		June 30,
		2023		2022		2022
Ending Membership by Segment:
Medicaid		4,741,000		4,754,000		4,610,000
Medicare		166,000		156,000		151,000
Marketplace		269,000		348,000		357,000
Total		5,176,000		5,258,000		5,118,000

	Three Months Ended June 30,
	2023									2022
	Premium Revenue			Medical Margin			MCR (1)			Premium Revenue			Medical Margin			MCR (1)
Medicaid	$	6,485		$	756		88.3	%		$	6,301		$	755		88.0	%
Medicare		1,044			113		89.2				957			124		86.9
Marketplace		513			135		73.7				541			48		91.2
Consolidated	$	8,042		$	1,004		87.5	%		$	7,799		$	927		88.1	%

	Six Months Ended June 30,
	2023									2022
	Premium Revenue			Medical Margin			MCR (1)			Premium Revenue			Medical Margin			MCR (1)
Medicaid	$	12,834		$	1,490		88.4	%		$	12,281		$	1,465		88.1	%
Medicare		2,090			239		88.6				1,900			252		86.7
Marketplace		1,003			289		71.2				1,149			178		84.5
Consolidated	$	15,927		$	2,018		87.3	%		$	15,330		$	1,895		87.6	%

__________________

(1)

The MCR represents medical costs as a percentage of premium revenue.

MOLINA HEALTHCARE, INC.

CHANGE IN MEDICAL CLAIMS AND BENEFITS PAYABLE

(Dollars in millions)

The Company’s claims liabilities include additional reserves to account for moderately adverse conditions based on historical experience and other factors including, but not limited to, variations in claims payment patterns, changes in utilization and cost trends, known outbreaks of disease, and large claims. The Company’s reserving methodology is consistently applied across all periods presented. The amounts displayed for “Components of medical care costs related to: Prior year” represent the amounts by which the original estimates of claims and benefits payable at the beginning of the year were more than the actual liabilities based on information (principally the payment of claims) developed since those liabilities were first reported. The following table presents the components of the change in medical claims and benefits payable for the periods indicated:

	Six Months Ended
	June 30,
		2023				2022
	Unaudited
Medical claims and benefits payable, beginning balance	$	3,528			$	3,363
Components of medical care costs related to:
Current year		14,180				13,746
Prior year		(271	)			(311	)
Total medical care costs		13,909				13,435
Payments for medical care costs related to:
Current year		11,166				10,622
Prior year		2,650				2,411
Total paid		13,816				13,033
Acquired balances, net of post-acquisition adjustments		—				7
Change in non-risk and other provider payables		56				3
Medical claims and benefits payable, ending balance	$	3,677			$	3,775
Days in Claims Payable (1)		47				50

__________________

(1)

The Company calculates Days in Claims Payable using claims incurred but not paid, or IBNP, and other fee-for-service payables included in medical claims and benefits payable, and quarterly fee-for-service related costs included in medical care costs within the Company’s consolidated financial statements.

MOLINA HEALTHCARE, INC.

RECONCILIATION OF UNAUDITED NON-GAAP FINANCIAL MEASURES

(In millions, except per diluted share amounts)

The Company believes that certain non-GAAP (generally accepted accounting principles) financial measures are useful supplemental measures to investors in comparing the Company’s performance to the performance of other public companies in the health care industry. The non-GAAP financial measures are also used internally to enable management to assess the Company’s performance consistently over time. These non-GAAP financial measures, presented below, should be considered as supplements to, and not as substitutes for or superior to, GAAP measures.

Adjustments represent additions and deductions to GAAP net income as indicated in the table below, which include the non-cash impact of amortization of acquired intangible assets, acquisition-related expenses, and the impact of certain expenses and other items that management believes are not indicative of longer-term business trends and operations.

Adjusted G&A Ratio represents the GAAP G&A ratio, recognizing adjustments.

Adjusted net income represents GAAP net income recognizing the adjustments, net of tax. The Company believes that adjusted net income is helpful to investors in assessing the Company’s financial performance.

Adjusted net income per diluted share represents adjusted net income divided by weighted average common shares outstanding on a fully diluted basis.

Adjusted after-tax margin represents adjusted net income, divided by total revenue.

	Three Months Ended June 30,																Six Months Ended June 30,
	2023								2022								2023								2022
	Amount				Per Diluted Share				Amount				Per Diluted Share				Amount				Per Diluted Share				Amount				Per Diluted Share
GAAP Net income	$	309			$	5.35			$	248			$	4.25			$	630			$	10.87			$	506			$	8.63
Adjustments:
Amortization of intangible assets	$	22			$	0.36			$	19			$	0.33			$	43			$	0.73			$	37			$	0.63
Acquisition-related expenses (1)		2				0.03				7				0.11				2				0.03				26				0.45
Other (2)		—				—				(3	)			(0.04	)			—				—				—				—
Subtotal, adjustments		24				0.39				23				0.40				45				0.76				63				1.08
Income tax effect		(6	)			(0.09	)			(5	)			(0.10	)			(11	)			(0.18	)			(15	)			(0.26	)
Adjustments, net of tax		18				0.30				18				0.30				34				0.58				48				0.82
Adjusted net income	$	327			$	5.65			$	266			$	4.55			$	664			$	11.45			$	554			$	9.45

__________________

(1)		Reflects non-recurring costs associated with acquisitions, including various transaction and certain integration costs.
(2)		The first half of 2022 includes certain non-recurring costs associated with gain on lease termination and disposal of fixed assets.

MOLINA HEALTHCARE, INC.
RECONCILIATION OF UNAUDITED NON-GAAP FINANCIAL MEASURES (CONTINUED)
2023 GUIDANCE
	Amount				Per Diluted Share (2)
GAAP Net income	$	1,137			$	19.51
Adjustments:
Amortization of intangible assets		87				1.50
Acquisition-related expenses		3				0.05
Subtotal, adjustments		90				1.55
Income tax effect (1)		(21	)			(0.31	)
Adjustments, net of tax		69				1.24
Adjusted net income	$	1,206			$	20.75

__________________

(1)		Income tax effect calculated at the statutory tax rate of approximately 25.3%.
(2)		Computations assume approximately 58.1 million diluted weighted average shares outstanding.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20230726599444/en/

The Molina Healthcare Stock at the time of publication of the news with a fall of -1,82 % to 280,4EUR on Lang & Schwarz stock exchange (26. Juli 2023, 22:24 Uhr).